European Archives - Page 95 of 1211 - European Medical Journal

Physical Activity Key to Longevity in Women After Cancer

Physical activity is emerging as a critical factor in women’s health after cancer, with new evidence showing lower mortality among postmenopausal survivors who move more and sit less.

Perinatal Antibiotic Exposure Tied to Impaired Lung Function in Childhood

Repeated exposure to antibiotics during the perinatal period in very low birth weight preterm infants is associated with impaired lung function by early school age.

Ambulation Recovery Key in Metastatic Femur Fractures

Restoring walking ability after surgery for femoral metastasis is strongly tied to improved one-year survival, with early surgery and chemotherapy aiding recovery.

Clinical Insights in Rheumatology

In this three-part series, Jonathan Sackier sits down with Richard Conway, rheumatologist, researcher, and educator. Together, they delve into cutting-edge insights on polymyalgia rheumatica, immune ageing, and the future of rheumatology care.

Oral Nutraceutical Shows Promise for Treating Acne

A study has shed new light on a novel approach to managing acne vulgaris, highlighting the efficacy of an oral nutraceutical.

Breaking Barriers in Tuberculosis: Interview with Dirk Schnappinger

Dirk Schnappinger – Professor of Microbiology and Immunology, Weill Cornell Medical College, New York City, USA – Your lab has developed…

mCRPC Evolving Treatment Landscape

This is a non-promotional medical symposium funded and organised by Bayer. This presentation contains information on products, indications or combinations that are not licensed in all countries, or not licensed in any region. Please consult your local prescribing information for more information. This content is intended for healthcare professionals only.

Food Addiction and Taste Bud Rehab: Interview with David Katz

David Katz | Chief Medical Officer, Tangelo, Intend; Founder/CEO, DietID, Detroit, Michigan, USA. What initially sparked your interest in…

5 minutes with... Andrew Cooper, CEO, CluePoints

Discover Andrew Cooper’s passion for optimising clinical trials with AI, driving innovation and building a culture of teamwork and purpose.

Invasive E. coli Disease Risk After Urological Procedures

The study aimed to assess the risk of IED following urologic procedures with or without antibiotic prophylaxis.